References
- Lansbury J. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis: theoretic and clinical considerations. Arthritis Rheum 1958;1:505–22.
- Hamada K. The safety of Actarit (Mover) in hemodialysis patients with rheumatoid arthritis (in Japanese). Prog Med 1997;17:1652–7.
- Kaizu K, Komine N, Uriu K, Ikeda M, Hashimoto O, Eto S. Bucillamine may be an effective anti-rheumatic drug in patients with end-stage renal disease — a case report (in Japanese). J Jpn Soc Dial Ther 1994;27:1505–10.
- Matthey F, Perrett D, Greenwood RN, Baker LRI. The use of D-penicillamine in patients with rheumatoid arthritis undergoing he-modialysis. Clin Nephrol 1986;25:268–71.
- Nakayama K. Administration of mizoribine to patients on maintenance hemodialysis accompanied by rheumatoid arthritis (in Japanese). Miyazaki Ikai-shi 1994;18:203–9.
- Nakamura K, Sakemi T, Nagasawa K. Severe pancytopenia caused by a single administration of low-dose methotrexate in a patient undergoing hemodialysis. J Ftheumatol 1999;26:1424–5.
- Warabi H, Abe S, Kondo H, Ishihara Y, Sugawara S, Shichikawa K, et al. Consecutive administration of mizoribine in rheumatoid arthritis. Pharmacokinetic study (in Japanese). Ftheumatology 1991;5:287–300.
- Sonda K, Takahashi K, Tanabe K, Ohta K. Optimal dose of mizoribine for renal transplantation patients (in Japanese). Ther Res 1995;16:998–1003.
- Kashiwazaki S, Kondo H, Koike T, Saito T, Kasukawa R, Kashiwagi H, et al. Dose comparison of Bredinin on rheumatoid arthritis: a multicenter post-marketing surveillance study (in Japanese). Jpn J Inflamm 1996;16:269–89.
- Kohriyama K, Kohno A, Shiozawa K, Shiozawa S. The effective-ness of using Mizoribine to treat rheumatoid arthritis. A long term administration study (in Japanese). Chin Ftheumato11994;6:123–51.
- Kusaba R, Otubo O, Inou T, Tsujino M, Ishikawa H. Studies of pharmacokinetics of bredinin (in Japanese). Jpn J Transplant 1982;17 Suppl:5585–93.